286 related articles for article (PubMed ID: 21819911)
1. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A
J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911
[TBL] [Abstract][Full Text] [Related]
2. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
[TBL] [Abstract][Full Text] [Related]
5. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
9. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
10. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
Furlan A; Marin D; Cabassa P; Taibbi A; Brunelli E; Agnello F; Lagalla R; Brancatelli G
Eur J Radiol; 2012 Sep; 81(9):2099-105. PubMed ID: 21906896
[TBL] [Abstract][Full Text] [Related]
11. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V
J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
13. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
14. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Jeon TY; Kim SH; Lee WJ; Lim HK
Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
AJR Am J Roentgenol; 2007 Sep; 189(3):663-70. PubMed ID: 17715115
[TBL] [Abstract][Full Text] [Related]
16. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
Becker-Weidman DJ; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV; Farris AB; Martin DR
Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
[TBL] [Abstract][Full Text] [Related]
18. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
[TBL] [Abstract][Full Text] [Related]
19. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
[TBL] [Abstract][Full Text] [Related]
20. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]